Top Markets
#1 Siren Siren +38.57%
#2 RedStone RedStone +23.03%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Cysic Cysic +15.54%
#5 Ocean Protocol Ocean Protocol +15.53%
#6 Verus Coin Verus Coin +13.51%
#7 Arowana Arowana +13.51%
#8 KUB Coin KUB Coin +13.09%
#9 Perle Perle +12.59%
#10 Wiki Cat Wiki Cat +9.55%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Makers Laboratories Limited Makers Laboratories Limited

Makers Laboratories Limited

MAKERSL
Clasificación en acciones #32333
Makers Laboratories Ltd. functions as a pharmaceutical company, primarily... Makers Laboratories Ltd. functions as a pharmaceutical company, primarily focused on the creation, production, and sale of medicinal products. Its array of proprietary formulations features prominent brands like Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. Established on July 9, 1984, the firm's main corporate office is situated in Mumbai, India.
Precio por acción
$1.78
Capitalización bursátil
$10.48M
Cambio (1 día)
2.88%
Cambio (1 año)
4.77%
País
IN
Comercio Makers Laboratories Limited (MAKERSL)

Categoría

Healthcare
Ratio P/S de Makers Laboratories Limited (MAKERSL)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Makers Laboratories Limited, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Makers Laboratories Limited desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US